Stefanos Theoharis
Chief Executive Officer bij Onechain Immunotherapeutics
Profiel
Stefanos Theoharis is currently the Chief Executive Officer at Onechain Immunotherapeutics since 2024.
Previously, he worked as a Consultant at The London Technology Network, Head of Business Development at Isarna Therapeutics GmbH from 2011 to 2013, and Chief Business Officer at Bone Therapeutics SA. He completed his graduate and doctorate degrees from Imperial College London and his undergraduate degree from Royal Holloway University of London.
Actieve functies van Stefanos Theoharis
| Bedrijven | Functie | Begin |
|---|---|---|
Onechain Immunotherapeutics
 Onechain Immunotherapeutics Medical SpecialtiesHealth Technology Onechain Immunotherapeutics develops oncological therapeutic tools. The company is based in Barcelona, Spain. The Spanish company was founded in 2020 by Pablo Menéndez. The CEO is Jorge Alemany. | Chief Executive Officer | 01-02-2024 |
Eerdere bekende functies van Stefanos Theoharis
| Bedrijven | Functie | Einde |
|---|---|---|
Isarna Therapeutics GmbH
 Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany. | Corporate Officer/Principal | 01-02-2013 |
| BIOSENIC SA | Corporate Officer/Principal | - |
The London Technology Network
 The London Technology Network Other Consumer ServicesConsumer Services The London Technology Network provides academic training in computer science, life science and physical science. It also offers technology consulting services to member companies. The company is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Opleiding van Stefanos Theoharis
| Imperial College London | Doctorate Degree |
| Royal Holloway University of London | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
The London Technology Network
The London Technology Network Other Consumer ServicesConsumer Services The London Technology Network provides academic training in computer science, life science and physical science. It also offers technology consulting services to member companies. The company is headquartered in London, the United Kingdom. | Consumer Services |
Isarna Therapeutics GmbH
Isarna Therapeutics GmbH BiotechnologyHealth Technology Isarna Therapeutics GmbH engages in developing selective TGF-ß inhibitors. It works on a pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcome. The company focuses on biopharmaceutical research, pipeline development, and partnering and licensing programs. Isarna Therapeutics was founded by Karl-Hermann Schlingensiepen and Reimar Schlingensiepen in 1998 and is headquartered in Munich, Germany. | Health Technology |
Bone Therapeutics SA
 Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Bone Therapeutics SA is a cell therapy company, which engages in the regenerative therapy addressing for unmet medical needs in the field of bone diseases and orthopedics. Its products include Allob and JTA-004. The company was founded by Jacques Reymann on June 16, 2006 and is headquartered in Gosselies, Belgium. | Health Technology |
Onechain Immunotherapeutics
Onechain Immunotherapeutics Medical SpecialtiesHealth Technology Onechain Immunotherapeutics develops oncological therapeutic tools. The company is based in Barcelona, Spain. The Spanish company was founded in 2020 by Pablo Menéndez. The CEO is Jorge Alemany. | Health Technology |
